rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)

MLA

Conall H. Watson, et al. “RVSV-ZEBOV Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (l’essai Proches).” BMC Medicine, vol. 22, no. 1, Nov. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12916-024-03726-z.

APA

Conall H. Watson, Pierre-Stéphane Gsell, Yper Hall, Anton Camacho, Ximena Riveros, Godwin Enwere, Andrea Vicari, Séverine Danmadji Nadlaou, Alhassane Toure, Ismaila M. Sani, Abdourahamane Diallo, Cece Kolie, Sophie Duraffour, Kékoura Ifono, Andre Maomou, Kassie Dore, Honora A. Djidonou, Aminata Bagayoko, Philos P. Damey, … Ana Maria Henao-Restrepo. (2024). rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches). BMC Medicine, 22(1), 1–10. https://doi.org/10.1186/s12916-024-03726-z

Chicago

Conall H. Watson, Pierre-Stéphane Gsell, Yper Hall, Anton Camacho, Ximena Riveros, Godwin Enwere, Andrea Vicari, et al. 2024. “RVSV-ZEBOV Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (l’essai Proches).” BMC Medicine 22 (1): 1–10. doi:10.1186/s12916-024-03726-z.